Liver Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Diseases (Cirrhosis, Hepatitis, Cancer and Other Diseases), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities) and Geography
- THE3206851
- 115 Pages
- September 2018
- Medical Devices
Liver is an organ that is situated just below the rib cage and on the right side of the abdomen. As essential function of liver is to carry out digestion of food and ridding off the body from toxic substances. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol. Over the time, damage to the liver results in scarring, a condition known as liver cirrhosis. The condition of liver can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound. Key factors such as increasing prevalence of liver diseases, rising geriatric population suffering from liver diseases and various technological advancements in imaging techniques are key drivers for the growth of the market. However, factors such as stringent regulatory framework and high cost of imaging techniques for liver treatment are likely to restrain the market growth to a certain extent. On the other side, owing the benefits offered by the hybrid imaging systems over the standalone ones, its use is anticipated to one of the prevalent trend considerably over the forecast period.
The disease segment of the liver treatment market is segmented into open cancer. Hepatitis, cirrhosis, and others. In 2017, cancer held the largest market share. There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity. The segment is anticipated to grow with a CAGR of 5.2% during the forecast period.
The imaging modality segment of the liver treatment market is segmented into open computed tomography, magnetic resonance imaging (MRI), ultrasound and other imaging modalities. In 2017, the computed tomography segment is anticipated to attain maximum share and grow at the highest CAGR during the forecast period in the liver treatment market. A CT scan provides accurate information about the size, shape and position of any tumors in the liver or elsewhere in the abdomen, as well as nearby blood vessels. Hence, it is used to identify the location of a tumor, analyze the extent of cancer in the body and also determine whether the disease is responding to treatments. Advantages offered by CT over other modalities is likely to make the CT dominant over other modalities in the liver treatment market.
Some of the major primary and secondary sources included in the report for the liver treatment market are World Health Organization (WHO), American Cancer Society, National Institute for Health Research, Health Ministry in British Columbia, Center for Devices and Radiological Health, Organisation for Economic Cooperation and Development, Food and Drug Administration, American Association for the Study of Liver Diseases, and Health Protection Agency among others.
1. INTRODUCTION 14
1.1 SCOPE OF THE STUDY 14
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 14
2. GLOBAL LIVER TREATMENT MARKET - KEY TAKEAWAYS 15
3. GLOBAL LIVER TREATMENT MARKET - MARKET LANDSCAPE 17
3.1 OVERVIEW 17
3.2 MARKET SEGMENTATION 17
3.2.1 Global Liver Treatment Market - By Disease 18
3.2.2 Global Liver Treatment Market - By Imaging Modality 18
3.2.3 Global Liver Treatment Market - By Geography 19
4. GLOBAL LIVER TREATMENT MARKET - KEY MARKET DYNAMICS 20
4.1 KEY MARKET DRIVERS 20
4.1.1 Increasing Prevalence of Liver Diseases 20
4.1.2 Increasing Geriatric Population 20
4.1.3 Technological Advancements in Imaging Techniques 21
4.2 KEY MARKET RESTRAINTS 21
4.2.1 Stringent Regulatory Validation Requirement 21
4.2.2 High Cost of Imaging Techniques 21
4.3 KEY MARKET OPPORTUNITIES 22
4.3.1 Partnerships and Collaborations Between Market Players 22
4.3.2 Increasing Healthcare Expenditures in Emerging Markets 22
4.4 FUTURE TRENDS 23
4.4.1 Increasing Use of Hybrid Systems for Imaging 23
4.5 IMPACT ANALYSIS 24
5. LIVER TREATMENT MARKET -GLOBAL ANALYSIS 25
5.1 LIVER TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 25
5.2 GLOBAL LIVER TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 25
5.3 EXPERT OPINIONS 26
6. GLOBAL LIVER TREATMENT MARKET ANALYSIS - BY DISEASES 27
6.1 OVERVIEW 27
6.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE 2017 & 2025 (%) 27
6.3 CANCER MARKET 28
6.3.1 Overview 28
6.3.2 Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn) 28
6.4 HEPATITIS MARKET 29
6.4.1 Overview 29
6.4.2 Global Hepatitis Market Revenue and Forecasts to 2025 (US$ Mn) 30
6.5 CIRRHOSIS MARKET 31
6.5.1 Overview 31
6.5.2 Global Cirrhosis Market Revenue and Forecasts to 2025 (US$ Mn) 31
6.6 OTHER DISEASES MARKET 32
6.6.1 Overview 32
6.6.2 Global Other Diseases Market Revenue and Forecasts to 2025 (US$ Mn) 32
7. GLOBAL LIVER TREATMENT MARKET ANALYSIS - BY IMAGING MODALITY 33
7.1 OVERVIEW 33
7.2 GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY 2017 & 2025 (%) 33
7.3 COMPUTED TOMOGRAPHY (CT) MARKET 34
7.3.1 Overview 34
7.3.2 Global Computed Tomography (CT) Market Revenue and Forecasts to 2025 (US$ Mn) 34
7.4 MAGNETIC RESONANCE IMAGING (MRI) MARKET 35
7.4.1 Overview 35
7.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2025 (US$ Mn) 35
7.6 ULTRASOUND MARKET 36
7.6.1 Overview 36
7.6.2 Global Ultrasound Market Revenue and Forecasts to 2025 (US$ Mn) 36
7.7 OTHER IMAGING MODALITIES MARKET 37
7.7.1 Overview 37
7.7.2 Global Other Imaging Modalities Market Revenue and Forecasts to 2025 (US$ Mn) 37
8. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 38
8.1 OVERVIEW 38
8.2 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
8.3 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 39
8.4 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 40
8.5 NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 40
8.6 US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 41
8.6.1 US Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 42
8.6.2 US Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 42
8.6.3 US Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 43
8.7 CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
8.7.1 Canada Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 44
8.7.2 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 45
8.7.3 Canada Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 45
8.8 MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
8.8.1 Mexico Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 46
8.8.2 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 47
8.8.3 Mexico Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 47
9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 48
9.1 OVERVIEW 48
9.2 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
9.3 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
9.4 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 50
9.5 EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
9.6 GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
9.6.1 Germany Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 51
9.6.2 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
9.6.3 Germany Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 52
9.7 FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
9.7.1 France Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 53
9.7.2 France Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
9.7.3 France Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 54
9.8 UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
9.8.1 UK Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 55
9.8.2 UK Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56
9.8.3 UK Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 56
10. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 57
10.1 OVERVIEW 57
10.2 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
10.3 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 58
10.4 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 59
10.5 ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 59
10.6 JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
10.6.1 Japan Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 60
10.6.2 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 61
10.6.3 Japan Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 61
10.7 CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
10.7.1 China Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 62
10.7.2 China Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 63
10.7.3 China Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 63
10.8 INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
10.8.1 India Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 64
10.8.2 India Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 65
10.8.3 India Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 65
11. MIDDLE EAST AND AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 66
11.1 OVERVIEW 66
11.2 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
11.3 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 67
11.4 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 68
11.5 MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 68
11.6 UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
11.6.1 UAE Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 69
11.6.2 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 70
11.6.3 UAE Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 70
11.7 SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
11.7.1 Saudi Arabia Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 71
11.7.2 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
11.7.3 Saudi Arabia Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 72
11.8 SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
11.8.1 South Africa Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 73
11.8.2 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
11.8.3 South Africa Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 74
12. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 75
12.1 OVERVIEW 75
12.2 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
12.3 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
12.4 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 77
12.5 SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77
12.6 BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
12.6.1 Brazil Liver Treatment Market Revenue and Forecasts to 2025 (US$ Mn) 78
12.6.2 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 79
12.6.3 Brazil Liver Treatment Market Revenue And Forecasts to 2025, By Imaging Modality (US$ Mn) 79
13. LIVER TREATMENT MARKET -KEY COMPANY PROFILES 80
13.1 GENERAL ELECTRIC 80
13.1.1 Key Facts 80
13.1.2 Business Description 80
13.1.3 Financial Overview 81
13.1.4 Product Portfolio 81
13.1.5 SWOT Analysis 82
13.1.6 Key Developments 82
13.2 KONINKLIJKE PHILIPS N.V. 83
13.2.1 Key Facts 83
13.2.2 Business Description 83
13.2.3 Financial Overview 84
13.2.4 Product Portfolio 84
13.2.5 SWOT Analysis 85
13.2.6 Key Developments 85
13.3 SIEMENS AG 86
13.3.1 Key Facts 86
13.3.2 Business Description 86
13.3.3 Financial Overview 87
13.3.4 Product Portfolio 87
13.3.5 SWOT Analysis 88
13.3.6 Key Developments 88
13.4 CANON MEDICAL SYSTEMS CORPORATION 89
13.4.1 Key Facts 89
13.4.2 Business Description 89
13.4.3 Financial Overview 90
13.4.4 Product Portfolio 90
13.4.5 SWOT Analysis 91
13.4.6 Key Developments 91
13.5 HITACHI, LTD 92
13.5.1 Key Facts 92
13.5.2 Business Description 92
13.5.3 Financial Overview 92
13.5.4 Product Portfolio 93
13.5.5 SWOT Analysis 93
13.5.6 Key Developments 94
13.6 ELEKTA AB (PUB) 95
13.6.1 Key Facts 95
13.6.2 Business Description 95
13.6.3 Financial Overview 96
13.6.4 Product Portfolio 96
13.6.5 SWOT Analysis 97
13.6.6 Key Developments 97
13.7 NEUSOFT CORPORATION 98
13.7.1 Key Facts 98
13.7.2 Business Description 98
13.7.3 Financial Overview 99
13.7.4 Product Portfolio 99
13.7.5 SWOT Analysis 100
13.7.6 Key Developments 100
13.8 SAMSUNG HEALTHCARE 101
13.8.1 Key Facts 101
13.8.2 Business Description 101
13.8.3 Financial Overview 102
13.8.4 Product Portfolio 102
13.8.5 SWOT Analysis 102
13.8.6 Key Developments 102
13.9 BPL MEDICAL TECHNOLOGIES 103
13.9.1 Key Facts 103
13.9.2 Business Description 103
13.9.3 Financial Overview 103
13.9.4 Product Portfolio 103
13.9.5 SWOT Analysis 104
13.9.6 Key Developments 104
13.10 CURA HEALTHCARE 105
13.10.1 Key Facts 105
13.10.2 Business Description 105
13.10.3 Financial Overview 105
13.10.4 Product Portfolio 106
13.10.5 SWOT Analysis 106
13.10.6 Key Developments 107
14. APPENDIX 108
14.1 ABOUT THE INSIGHT PARTNERS 108
14.2 GLOSSARY OF TERMS 109
14.3 METHODOLOGY 111
14.3.1 Coverage 112
14.3.2 Secondary Research 113
14.3.3 Primary Research 113
LIST OF TABLES
TABLE 1. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 40
TABLE 2. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 41
TABLE 3. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 43
TABLE 4. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 44
TABLE 5. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 46
TABLE 6. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 46
TABLE 7. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 48
TABLE 8. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 48
TABLE 9. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 50
TABLE 10. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 51
TABLE 11. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 53
TABLE 12. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 53
TABLE 13. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 55
TABLE 14. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 55
TABLE 15. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 57
TABLE 16. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 57
TABLE 17. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 18. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 60
TABLE 19. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 20. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 62
TABLE 21. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
TABLE 22. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 64
TABLE 23. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
TABLE 24. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 66
TABLE 25. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 68
TABLE 26. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 69
TABLE 27. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 71
TABLE 28. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 71
TABLE 29. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 73
TABLE 30. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 73
TABLE 31. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 75
TABLE 32. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 75
TABLE 33. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 77
TABLE 34. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 78
TABLE 35. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 80
TABLE 36. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY IMAGING MODALITY (US$ MN) 80
TABLE 37. GLOSSARY OF TERMS, LIVER TREATMENT MARKET 110
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 16
FIGURE 2. GLOBAL LIVER TREATMENT MARKET BY DISEASE, MARKET SHARE (%), 2017 17
FIGURE 3. GLOBAL LIVER TREATMENT MARKET BY IMAGING MODALITY, MARKET SHARE (%), 2017 17
FIGURE 4. LIVER TREATMENT MARKET SEGMENTATION 18
FIGURE 5. LIVER TREATMENT SEGMENTATION, BY REGION 19
FIGURE 6. LIVER TREATMENT MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 25
FIGURE 7. GLOBAL LIVER TREATMENT MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025 26
FIGURE 8. GLOBAL LIVER TREATMENT MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 27
FIGURE 9. GLOBAL LIVER TREATMENT MARKET SHARE, BY DISEASE, 2017 & 2025 (%) 28
FIGURE 10. GLOBAL CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 29
FIGURE 11. GLOBAL HEPATITIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 31
FIGURE 12. GLOBAL CIRRHOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 32
FIGURE 13. GLOBAL OTHER DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 33
FIGURE 14. GLOBAL LIVER TREATMENT MARKET SHARE, BY IMAGING MODALITY, 2017 & 2025 (%) 34
FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
FIGURE 16. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
FIGURE 17. GLOBAL ULTRASOUND MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 37
FIGURE 18. GLOBAL OTHER IMAGING MODALITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
FIGURE 19. NORTH AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 39
FIGURE 20. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 21. NORTH AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 41
FIGURE 22. US LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 23. CANADA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 24. MEXICO LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 25. EUROPE LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 49
FIGURE 26. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 27. EUROPE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 51
FIGURE 28. GERMANY LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 29. FRANCE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 30. UK LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 31. ASIA PACIFIC LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 58
FIGURE 32. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 33. ASIA PACIFIC LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
FIGURE 34. JAPAN LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 35. CHINA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 36. INDIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 37. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 67
FIGURE 38. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 39. MIDDLE EAST & AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
FIGURE 40. UAE LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 41. SAUDI ARABIA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
FIGURE 42. SOUTH AFRICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 43. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET OVERVIEW, BY COUNTRY (2017) 76
FIGURE 44. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
FIGURE 45. SOUTH AND CENTRAL AMERICA LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 78
FIGURE 46. BRAZIL LIVER TREATMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
